Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
Sales | 13,598 | 14,604 | 11,898 | 13,959 | 12,153 |
Cost of Goods | 2,006 | 2,166 | 1,680 | 1,966 | 1,689 |
Gross Profit | 11,592 | 12,438 | 10,218 | 11,993 | 10,464 |
Operating Expenses | 15,009 | 14,578 | 15,045 | 15,711 | 13,175 |
Operating Income | -3,411 | -1,974 | -4,147 | -2,752 | -2,022 |
Interest Expense | 1,500 | 1,383 | 1,364 | 1,363 | 1,360 |
Other Income | -334 | 259 | -444 | -24 | -970 |
Pre-tax Income | -5,245 | -3,098 | -5,955 | -4,139 | -4,352 |
Income Tax | 12 | 17 | N/A | -33 | -169 |
Net Income Continuous | -5,257 | -3,115 | -5,955 | -4,106 | -4,183 |
Net Income | $-5,257 | $-3,115 | $-5,955 | $-4,106 | $-4,183 |
EPS Basic Total Ops | -0.75 | -0.45 | -0.85 | -0.46 | -0.60 |
EPS Basic Continuous Ops | -0.75 | -0.45 | -0.85 | -0.45 | -0.60 |
EPS Diluted Total Ops | -0.75 | -0.45 | -0.85 | -0.46 | -0.60 |
EPS Diluted Continuous Ops | -0.75 | -0.45 | -0.85 | -0.45 | -0.60 |
EPS Diluted Before Non-Recurring Items | -0.75 | -0.45 | -0.85 | N/A | N/A |
EBITDA(a) | $-2,446 | $-1,023 | $-3,187 | $-1,851 | $-1,131 |